What Happened?
Valencia, CA-based SetPoint-Medical Appointed Murthy Simhambhatla as President and Chief Executive Officer
About the Company
SetPoint Medical is developing novel neuromodulation therapies to treat those who suffer from inflammatory diseases such as Crohn`s Disease and rheumatoid arthritis. The company is developing a proprietary and innovative neuromodulation therapy delivery platform consisting of a micro-regulator programmed via a unique prescription pad based interface. This novel therapy will provide patients and healthcare providers with a safe and efficacious alternative to drugs, while costing payors less than 50% of what today`s leading biologic therapies cost.
About the Person
Murthy Simhambhatla is President and Chief Executive Officer at SetPoint Medical. Previously, Murthy held various senior HR leadership roles in the industry.
Info Source
News
Short Profile